Shares of UiPath Inc PATH are down Friday despite the company's reporting in-line fiscal second-quarter results. Here are some key analyst takeaways: BMO Capital Markets analyst Keith Bachman maintained a Market Perform rating, while raising the price target from $14 to $15. DA Davidson analyst Gil Luria reaffirmed a Neutral rating, while lifting the price target from $13 to $15. JPMorgan analyst Mark Murphy reiterated an Overweight rating and price target of $19. RBC Capital Markets analyst Matthew Hedberg ...